Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine RaceThe Motley Fool • 12/10/20
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of DirectorsGlobeNewsWire • 12/09/20
$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest WinnersThe Motley Fool • 12/08/20